For the many patients with depression who haven’t found relief through medication, transcranial magnetic stimulation (TMS) – a noninvasive therapy that uses magnetic pulses to stimulate specific areas of the brain – has become an increasingly important treatment option. But the standard course of treatment requires daily clinic visits over six-to-eight weeks, a schedule that can be difficult for many patients to manage.
TMS is an established, increasingly important treatment option for treatment-resistant depression, and has been shown in large studies to significantly reduce symptoms in 60-70% percent of patients with 25-35% achieving remission. It is a covered benefit under most insurance plans.
New research from UCLA Health suggests that a significantly accelerated version of TMS treatment of five…